Cryptophycin anticancer drugs revisited.

Research output: Contribution to journalComment/debate

17 Scopus citations


A recent publication reveals the biosynthetic building blocks, genetic code, and broad substrate tolerance of the enzymes of the cryptophycin biosynthetic pathway. This work lays the foundation for the production of poorly accessible yet very promising members of this family of anticancer compounds from lichen cyanobacterial symbionts. Chemoenzymatic production or precursor-directed biosynthesis might bring candidates from this family of natural products back to clinical trials.

Original languageEnglish
Pages (from-to)747-750
Number of pages4
JournalACS Chemical Biology
Issue number12
StatePublished - Dec 15 2006

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine


Dive into the research topics of 'Cryptophycin anticancer drugs revisited.'. Together they form a unique fingerprint.

Cite this